-
ECONOMIC BURDEN OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS WITHOUT RELAPSES IN THE UAE: A COST-OF-ILLNESS ANALYSIS FROM A SOCIETAL PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY OF ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS: A NETWORK META-ANALYSIS OF PHASE III TRIALS
Aug 11, 2026, 17:16 PM -
EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION AND ANALYSIS OF FACTORS INFLUENCING REHABILITATION AMONG INFANTS DIAGNOSED WITH MUSCULAR TORTICOLLIS
Aug 11, 2026, 17:16 PM -
FROM EVIDENCE TO CONSENSUS: DEVELOPING A SET OF INDICATORS FOR A COMPREHENSIVE SOCIAL SUSTAINABILITY ASSESSMENT IN THE HEALTHCARE VALUE CHAIN
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS OF TREATMENTS FOR COMPLICATED URINARY TRACT INFECTIONS CAUSED BY MULTIDRUG-RESISTANT GRAM-NEGATIVE PATHOGENS
Aug 11, 2026, 17:16 PM -
STRONG ON THE OBJECTIVE, DIVERGENT ON THE SUBJECTIVE: ARTIFICIAL INTELLIGENCE (AI) VS. HUMAN CRITICAL APPRAISAL OF RANDOMIZED CONTROLLED TRIALS (RCTS)
Aug 11, 2026, 17:16 PM -
A SYSTEMATIC LITERATURE REVIEW OF HEALTH-RELATED QUALITY OF LIFE AND HEALTH UTILITY VALUES IN PATIENTS WITH HEPATITIS C VIRUS WITH AND WITHOUT SUSTAINED VIROLOGIC RESPONSE
Aug 11, 2026, 17:16 PM -
INSTITUTIONAL IMPLEMENTATION OF ESMO-MCBS VALUE ASSESSMENT IN ONCOLOGY FORMULARY MANAGEMENT: A TERTIARY HEALTHCARE SYSTEM STUDY
Aug 11, 2026, 17:16 PM -
REGULATORY POLICY AND THE ACCELERATION OF AI-ENABLED DIGITAL HEALTH INNOVATION: AN INTERRUPTED TIME SERIES ANALYSIS OF FDA DEVICE AUTHORIZATIONS (2016-2025)
Aug 11, 2026, 17:16 PM -
HETEROGENEITY OF EVENT-FREE SURVIVAL DEFINITION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
PLAYING THE WEIGHTING GAME: A TARGETED LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF WEIGHT REGAIN AFTER GLP-1 RECEPTOR AGONIST DISCONTINUATION AND IMPLICATIONS FOR HEALTHCARE RESOURCE USE
Aug 11, 2026, 17:16 PM -
OBLIGATIONS WITHOUT REMEDIES? APPEAL AND REVIEW PATHWAYS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
TRANSITION-LEVEL UTILITY IMPLICATIONS OF THE 2026 UK EQ-5D-5L VALUE SET: A COMPLETE HEALTH-STATE ANALYSIS
Aug 11, 2026, 17:16 PM -
KEY CONSIDERATIONS FOR THE DEVELOPMENT OF A NICE REFERENCE CASE EXTENSION IN MENTAL HEALTH DISORDERS
Aug 11, 2026, 17:16 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO COST-UTILITY ANALYSIS: A PROOF-OF-CONCEPT APPLICATION IN SEVERE ASTHMA BIOLOGICS
Aug 11, 2026, 17:16 PM -
CONFIRM, COMPLEMENT, CONTEXTUALIZE, THE 3CS OF RWE: HOW REAL-WORLD-EVIDENCE CAN SUPPORT ACCESS DECISIONS FOR NEW MEDICINES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND VALUE-BASED PRICE OF CT-152 FOR MAJOR DEPRESSIVE DISORDER IN JAPAN: A MARKOV MODEL ANALYSIS
Aug 11, 2026, 17:16 PM -
A STANDARDS-BASED GOVERNANCE FRAMEWORK FOR ARTIFICIAL INTELLIGENCE ASSISTED SYSTEMATIC LITERATURE REVIEWS UNDER THE EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
FROM HEALTH TECHNOLOGY ASSESSMENT TO CLINICAL GUIDELINES: APPLICABILITY OF THE NICE SEVERITY MODIFIER
Aug 11, 2026, 17:16 PM -
CONGENITAL MALFORMATIONS AMONG NEWBORNS EXPOSED IN UTERO TO DIFFERENT ANTIDEPRESSANT CLASSES DURING PREGNANCY: A DESCRIPTIVE REAL-WORLD ANALYSIS OF ELECTRONIC MEDICAL RECORDS
Aug 11, 2026, 17:16 PM
